| Title |
Minocycline for acne vulgaris: efficacy and safety
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2012
|
| DOI | 10.1002/14651858.cd002086.pub2 |
| Pubmed ID | |
| Authors |
Sarah E Garner, Anne Eady, Cathy Bennett, John Norman Newton, Karen Thomas, Catalin Mihai Popescu |
| Abstract |
Minocycline is an oral antibiotic used for acne vulgaris. Its use has lessened due to safety concerns (including potentially irreversible pigmentation), a relatively high cost, and no evidence of any greater benefit than other acne treatments. A modified-release version of minocycline is being promoted as having fewer side-effects. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 22% |
| France | 2 | 6% |
| Japan | 1 | 3% |
| United Kingdom | 1 | 3% |
| Brazil | 1 | 3% |
| China | 1 | 3% |
| Mexico | 1 | 3% |
| Unknown | 18 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 53% |
| Practitioners (doctors, other healthcare professionals) | 6 | 19% |
| Unknown | 9 | 28% |
Mendeley readers
The data shown below were compiled from readership statistics for 439 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Germany | 1 | <1% |
| Ireland | 1 | <1% |
| Chile | 1 | <1% |
| Peru | 1 | <1% |
| Qatar | 1 | <1% |
| Unknown | 432 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 57 | 13% |
| Researcher | 55 | 13% |
| Student > Bachelor | 46 | 10% |
| Student > Ph. D. Student | 41 | 9% |
| Student > Postgraduate | 31 | 7% |
| Other | 88 | 20% |
| Unknown | 121 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 155 | 35% |
| Nursing and Health Professions | 35 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 5% |
| Agricultural and Biological Sciences | 15 | 3% |
| Psychology | 14 | 3% |
| Other | 67 | 15% |
| Unknown | 131 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#1,461,559
of 25,584,565 outputs
Outputs from Cochrane database of systematic reviews
#3,146
of 13,156 outputs
Outputs of similar age
#8,527
of 186,370 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 218 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,370 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.